Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.63 |
| ▸ | CA2 | P00918 | 3/20 | 0.63 |
| ▸ | CA12 | O43570 | 2/20 | 0.63 |
| ▸ | CA7 | P43166 | 2/20 | 0.63 |
| ▸ | CA9 | Q16790 | 2/20 | 0.63 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.63 |
| ▸ | ESR1 | P03372 | 1/20 | 0.63 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | MAOA | P21397 | 1/20 | 0.61 |
| ▸ | NPC1 | O15118 | 3/20 | 0.56 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.56 |
| ▸ | MAPT | P10636 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | HPGD | P15428 | 4/20 | 0.54 |
| ▸ | HTT | P42858 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10702295 | 0.95 | CA12 (0.58) | CA1CA2CA12CA7CA9 | |
| SCHEMBL10702293 | 0.95 | CA12 (0.58) | CA1CA2CA12CA7CA9 | |
| SCHEMBL1537537 | 0.95 | NPC1 (0.60) | CA1CA2CA12CA7CA9 | |
| SCHEMBL8016724 | 0.92 | PARP10 (0.58) | CA1CA2CA12CA7CA9 | |
| SCHEMBL10967063 | 0.90 | NPC1 (0.56) | CA1CA2CA12CA7CA9 | |
| SCHEMBL14714526 | 0.90 | CA1 (0.53) | CA1CA2CA12CA7CA9 | |
| SCHEMBL10618582 | 0.86 | CA1 (0.66) | CA1CA2CA12CA7CA9 | |
| SCHEMBL9717141 | 0.86 | CA1 (0.66) | CA1CA2CA12CA7CA9 | |
| SCHEMBL11616195 | 0.86 | CA1 (0.66) | CA1CA2CA12CA7CA9 | |
| SCHEMBL9717146 | 0.86 | CA1 (0.66) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 259 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112252031-A | Fabric preparation process | 施央浓 | 2021-01-22 | — | — | CN | claimed |
| CN-111519271-B | Preparation process of heat-resistant protective fabric | 杭州润恒医疗器械有限公司 | 2021-01-05 | — | — | CN | claimed |
| CN-111519271-A | Preparation process of heat-resistant protective fabric | 卢再佰 | 2020-08-11 | — | — | CN | claimed |
| CN-105314767-B | A kind of processing method of uns-dimethylhydrazine waste water | 兰州大学 | 2017-11-10 | — | — | CN | claimed |
| CN-105111214-B | A kind of preparation method of pemetrexed disodium | 江西农业大学 | 2017-10-31 | — | — | CN | claimed |
| CN-105314767-A | Unsymmetrical dimethylhydrazine wastewater treatment method | UNIV LANZHOU | 2016-02-10 | — | — | CN | claimed |
| CN-105111214-A | Preparation method of pemetrexed disodium | UNIV JIANGXI AGRICULTURAL | 2015-12-02 | — | — | CN | claimed |
| CN-100513382-C | Method for synthesizing arotinoid acid and arotinoid ethylester, and its pharmaceutical application | MING ZHANG (CN) | 2009-07-15 | — | — | CN | claimed |
| CN-1830950-A | Method synthesizing arotinoid acid and arotinoid ethylester, and its pharmaceutical application | ZHANG MING (CN) | 2006-09-13 | — | — | CN | claimed |
| JP-1238584-A | — | — | None | — | — | JP | disclosed |
| CN-115380037-B | Compound, anti-reflection film comprising the same, and display device | SAMSUNG SDI CO.,LTD. (KR) | 2026-05-26 | — | — | CN | disclosed |
| US-12583874-B2 | Compound, anti-reflection film comprising same, and display device | SAMSUNG SDI CO., LTD. (KR) | 2026-03-24 | — | — | US | disclosed |
| US-20260021068-A1 | METHODS AND COMPOSITIONS FOR INHIBITION OF TYROSINE AND PHENYLALANINE-MEDIATED DNA DAMAGE AND REPAIR | UNIV SOUTH CAROLINA (US) | 2026-01-22 | — | — | US | disclosed |
| CN-119874257-A | Color asphalt ultrathin wearing layer and preparation method thereof | 江苏增光新材料科技股份有限公司 | 2025-04-25 | — | — | CN | disclosed |
| US-4104468-A | 1,3,4-Oxadiazolyl-(2)-vinyl stilbene optical brighteners | SANDOZ LTD. (CH) | 1978-08-01 | — | — | US | disclosed |
| US-4070352-A | COLORFAST, SUBLIMATION AND OZONE RESISTANT BLUE AZO DYES FOR POLYAMIDES | EASTMAN KODAK COMPANY (US) | 1978-01-24 | — | — | US | disclosed |
| US-4035395-A | Process for the preparation of ketones | BAYER AKTIENGESELLSCHAFT (DT) | 1977-07-12 | — | — | US | disclosed |
| US-4024159-A | Process for the production of liquid acetals | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-05-17 | — | — | US | disclosed |
| US-4017313-A | Photosensitive composition containing a leuco dye, a photosensitizer, an aromatic aldehyde and a secondary or tertiary amine and the use thereof in a direct-print process | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1977-04-12 | — | — | US | disclosed |
| US-4014889-A | Process for preparing ketones | BAYER AKTIENGESELLSCHAFT (DT) | 1977-03-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12583874-B2 | Compound, anti-reflection film comprising same, and display device | KISS1R, CCKAR, TACR2 | CA1 1557/4885CA2 2645/4885CA12 702/4885 |
| US-20260021068-A1 | METHODS AND COMPOSITIONS FOR INHIBITION OF TYROSINE AND PHENYLALANINE-MEDIATED DNA DAMAGE AND REPAIR | NPY1R, TDP1, BDNF | CA1 1993/4885CA2 1625/4885CA12 4651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.